James Tomasino, Managing Partner – Technology; David Brous, Managing Partner – Creative; Marcos Sanchez, Founding Managing Partner;“Pharma companies continue to shift towards greater specialization, leaner budgets, shorter timelines, and the pressure to do more with less. There’s a massive need for a partner to help them maximize ROI and marketing goals. In the highly regulated pharmaceutical industry, a complex mix of strategy, creativity, and tech is required to meet the current and future needs of HCPs, patients, caregivers, payors, PBMs, and more,” says Marcos Sanchez, founding managing partner, Princeton10 (P10).
P10 stands out for its innovative approach and client-centric ethos in the ever-evolving pharmaceutical marketing space. Recognizing the growing need for agile, high-quality, and strategically adept marketing services, the company defies traditional agency norms and delivers exceptional value to clients. Today, P10 operates as a distinctive entity—a marketing partner rather than an agency—to help clients accomplish more with limited resources.
“Many healthcare advertising agencies, including those owned by large holding companies, are still structured like it’s the 1980s. Legacy economics has allowed them to become fat, bloated dinosaurs fighting over shrinking client budgets while trying to evolve into digital, which is no longer relevant,” says Sanchez. “This is where we act as the missing link in the chain of pharmaceutical marketing. Our structure, expertise, and dedication redefine success for our clients.”
Maximizing the Marketing Coverage
Amid ongoing price pressure from payors, pharmaceutical manufacturers transfer this strain to their advertising agencies. Navigating an ever-evolving landscape that's increasingly technology-centered and culturally diverse presents a formidable challenge for these manufacturers. In this new era of customer-driven marketing, the crux lies in relevance.
Catering primarily to small and mid-sized pharmaceutical companies, P1O thrives on filling resource gaps within brand teams by catering primarily to small and mid-sized pharmaceutical companies. As genuine collaborators, not just service providers, each member brings senior-level expertise across brand planning, creativity, and technology. P10’s distinctive prowess lies in delivering precisely what clients request, supplemented by integral yet unforeseen facets of the marketing puzzle. “Market Access issues for most pharma-focused agencies are a ‘third rail.’ At P10, we agree that it’s the third rail that provides all the power to move forward, and if you don’t have a solid understanding of its importance, you don’t deserve to be in this business anymore. Market Access makes or breaks brands in many therapeutic areas. At P10, we have decades of experience helping our clients maximize and get better coverage, and avoid areas of peril,” says Jack Bilson, Princeton10’s managed access and media lead.
The Answer to the Evolving Landscape
Unlike agencies characterized by layered staffing, P10’s leadership and senior talent engage directly in every client execution. Their work spans three core categories—brand planning/strategy, creative, and technology—a comprehensive suite of capabilities pivotal in addressing diverse client needs.
An illustrative testament to P10’s approach lies in handling a recent client request for a website promoting a newly acquired ADHD treatment. Going beyond the prescribed task, it embarked on a holistic journey, starting with extensive research, crafting brand positioning, and culminating in a website that not only met but exceeded the client’s expectations—reflecting empathy and resonating with caregiver concerns.
Delivering Real-Time, Culturally Attuned Experiences
What sets P10 apart is its commitment to efficiency, measurability, and agility. Operating on a fixed-fee basis, devoid of billable hours, the company embodies a model that demands precision from seasoned professionals, driving enhanced outcomes for clients, especially smaller companies mindful of every expenditure. “We do not count hours. We count opportunities to drive improved results for our clients,” says Sanchez.
We've shifted from an outdated model to a future-ready approach. Legacy structures no longer align with the dynamic needs of the industry. P10 is the answer to this ever-evolving landscape.

-
Pharma companies continue to shift toward greater specialization, leaner budgets, shorter timelines, and the pressure to do more with less. There's a massive need for a partner to help them maximize ROI and marketing goals. In the highly regulated pharmaceutical industry, a complex mix of strategy, creativity, and tech is required to meet the current and future needs of HCPs, patients, payors, PBMs, and more.
It stands as a beacon of innovation, efficiency, and personalized expertise, offering a comprehensive suite of services tailored to the ever-evolving needs of the pharmaceutical industry. P10 isn’t just a partner; it’s an indispensable ally empowering healthcare brands to reach their zenith and a marketing partner redefining industry standard—one collaboration at a time.


